Frequently Asked Questions

Here are some of the most common questions asked of our staff. 

If you have further questions, please call (888) 884-7515 or see our contact page

EZDebride is a Class 1 Medical Device that is registered, listed and made in the U.S.A.

Yes: the EZDebride Wound Instrument is a sharp debridement tool that will effectively debride biofilm, bio-burden, and tissue slough from the surface of the wounds. It’s unique cutting flute system along with a broad head provides precise controlled depth sharp debridement with minimal to no injury or insult to the underlying healthy tissue.

EZDebride comes in a box containing 8 sterile EZDebrides.

The EZDebride Wound Instrument unlike scalpels or curettes provides for a uniform, controlled depth sharp debridement. The EZDebride instrument has been shown to be less painful with a decrease in wound surface hemorrhaging.

Establish an account and contact us here.

Although EZDebride heavily reduces the amount of pain endured by a patient receiving sharp debridement, topical anesthesia can be used depending on the comfort level of the patient.

No: the EZDebride Wound Instrument is a single use, FDA approved class 1 device and is sterilized. It is packaged as a single unit.

For pricing, please contact sales@mdmwoundventures.com for your representative or distributor partner in your area.

For DoD, VA and Government agencies contact sales@bmkventures.com

Available on DAPA Contract# DAPA SP0200-18-H-0012

It can be used for callous however the condition and amount of callous will determine the best tool to use.

The EZDebride Wound Instrument can be used on many types of wounds including superficial eschars. However, if the eschar is well adhered and considered deep, it is not recommended to use the EZDebride instrument. If the wound surface eschar is superficial, dry, friable and loose, the EZDebride can be used.

The EZDebride Wound Instrument is a sharp debridement instrument and the clinician can be reimbursed under the debridement codes: 97597, 97598 (superficial to dermis and subcutaneous respectfully), 11042, and 11043. It is also recommended that all necessary documentation is completed and expressed under Medicare/Medicaid standards such as wound dimensions, objective findings, and wound details, etc. prior.